121 related articles for article (PubMed ID: 20857064)
1. [Graves disease and IgA deficiency as manifestations of 22q11.2 deletion syndrome].
Silva JM; Silva CP; Melo FF; Silva LA; Utagawa CY
Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):572-7. PubMed ID: 20857064
[TBL] [Abstract][Full Text] [Related]
2. Graves' disease in DiGeorge syndrome: patient report with a review of endocrine autoimmunity associated with 22q11.2 deletion.
Brown JJ; Datta V; Browning MJ; Swift PG
J Pediatr Endocrinol Metab; 2004 Nov; 17(11):1575-9. PubMed ID: 15570997
[TBL] [Abstract][Full Text] [Related]
3. Atypical language characteristics and trajectories in children with 22q11.2 deletion syndrome.
Van Den Heuvel E; Manders E; Swillen A; Zink I
J Commun Disord; 2018; 75():37-56. PubMed ID: 30005318
[TBL] [Abstract][Full Text] [Related]
4. Orthopaedic manifestations within the 22q11.2 Deletion syndrome: A systematic review.
Homans JF; Tromp IN; Colo D; Schlösser TPC; Kruyt MC; Deeney VFX; Crowley TB; McDonald-McGinn DM; Castelein RM
Am J Med Genet A; 2018 Oct; 176(10):2104-2120. PubMed ID: 29159873
[TBL] [Abstract][Full Text] [Related]
5. Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome.
Lin HY; Tsai WY; Tung YC; Liu SY; Lee NC; Chien YH; Hwu WL; Lee CT
Front Endocrinol (Lausanne); 2022; 13():771100. PubMed ID: 35432203
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative disorder with polyautoimmunity and hypogammaglobulinemia: An unusual presentation of 22q11.2 deletion syndrome.
Soares DC; Dantas AG; Matta MC; Pastorino AC; Melaragno MI; Kulikowski L; Montenegro M; Kim CA; Carneiro-Sampaio M; Torres LC
Clin Immunol; 2020 Nov; 220():108590. PubMed ID: 32920211
[TBL] [Abstract][Full Text] [Related]
7. Growth characteristics and endocrine abnormalities in 22q11.2 deletion syndrome.
Levy-Shraga Y; Gothelf D; Goichberg Z; Katz U; Somech R; Pinhas-Hamiel O; Modan-Moses D
Am J Med Genet A; 2017 May; 173(5):1301-1308. PubMed ID: 28421700
[TBL] [Abstract][Full Text] [Related]
8. [22q11.2 microdeletion syndrome: Analysis of the care pathway before the genetic diagnosis].
Ingrao T; Lambert L; Valduga M; Bosser G; Albuisson E; Leheup B
Arch Pediatr; 2017 Nov; 24(11):1067-1075. PubMed ID: 28967605
[TBL] [Abstract][Full Text] [Related]
9. Head and neck manifestations of 22q11.2 deletion syndromes.
Marom T; Roth Y; Goldfarb A; Cinamon U
Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):381-7. PubMed ID: 21861138
[TBL] [Abstract][Full Text] [Related]
10. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
[TBL] [Abstract][Full Text] [Related]
11. Candidate modifier genes for immune function in 22q11.2 deletion syndrome.
Pinnaro CT; Henry T; Major HJ; Parida M; DesJardin LE; Manak JR; Darbro BW
Mol Genet Genomic Med; 2020 Jan; 8(1):e1057. PubMed ID: 31830774
[TBL] [Abstract][Full Text] [Related]
12. Referential communication abilities in children with 22q11.2 deletion syndrome.
Van Den Heuvel E; ReuterskiöLd C; Solot C; Manders E; Swillen A; Zink I
Int J Speech Lang Pathol; 2017 Oct; 19(5):490-502. PubMed ID: 27690637
[TBL] [Abstract][Full Text] [Related]
13. Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome.
Davies K; Stiehm ER; Woo P; Murray KJ
J Rheumatol; 2001 Oct; 28(10):2326-34. PubMed ID: 11669177
[TBL] [Abstract][Full Text] [Related]
14. Antibody deficiency in adults with 22q11.2 deletion syndrome.
Björk AH; Óskarsdóttir S; Andersson BA; Friman V
Am J Med Genet A; 2012 Aug; 158A(8):1934-40. PubMed ID: 22786729
[TBL] [Abstract][Full Text] [Related]
15. Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome.
Lasprilla-Tovar J; Zuluaga NA; Forero C; Correa-Jiménez O; Sierra JM
J Clin Res Pediatr Endocrinol; 2023 Feb; 15(1):16-24. PubMed ID: 35984227
[TBL] [Abstract][Full Text] [Related]
16. Reproductive Health Issues for Adults with a Common Genomic Disorder: 22q11.2 Deletion Syndrome.
Chan C; Costain G; Ogura L; Silversides CK; Chow EW; Bassett AS
J Genet Couns; 2015 Oct; 24(5):810-21. PubMed ID: 25579115
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment of 22q11.2 deletion syndrome-related psychoses.
Boot E; Butcher NJ; Vorstman JA; van Amelsvoort TA; Fung WL; Bassett AS
Pharmacopsychiatry; 2015 Sep; 48(6):219-20. PubMed ID: 26091278
[TBL] [Abstract][Full Text] [Related]
18. Two novel mouse models mimicking minor deletions in 22q11.2 deletion syndrome revealed the contribution of each deleted region to psychiatric disorders.
Saito R; Miyoshi C; Koebis M; Kushima I; Nakao K; Mori D; Ozaki N; Funato H; Yanagisawa M; Aiba A
Mol Brain; 2021 Apr; 14(1):68. PubMed ID: 33845872
[TBL] [Abstract][Full Text] [Related]
19. Negative and paranoid symptoms are associated with negative performance beliefs and social cognition in 22q11.2 deletion syndrome.
Schneider M; Van der Linden M; Menghetti S; Debbané M; Eliez S
Early Interv Psychiatry; 2017 Apr; 11(2):156-164. PubMed ID: 25726949
[TBL] [Abstract][Full Text] [Related]
20. [Child psychiatry interventions in patients with 22q11 deletion syndrome: From treatment to prevention].
Novo A; Woestelandt L; Rousselot-Pailley B; Leitgel M; Eutrope J; Rio M; Lyonnet S; Robel L
Encephale; 2019 Apr; 45(2):175-181. PubMed ID: 30470499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
